Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is a successful intracellular pathogen that is responsible for the highest mortality rate among diseases caused by bacterial infections.
During early interaction with the host innate cells, M. tuberculosis cell surface antigens interact with Toll like receptor 4 (TLR4) to activate the nucleotide-binding domain, leucine-rich-repeat containing family, pyrin domain-containing 3 (NLRP3) canonical, and non-canonical inflammasome pathways.
NLRP3 inflammasome activation in the alveoli has been reported to contribute to the early inflammatory response that is needed for an effective anti-TB response through production of pro-inflammatory cytokines, including those of the Interleukin 1 (IL1) family.
However, overstimulation of the alveolar NLRP3 inflammasomes can induce excessive inflammation that is pathological to the host. Several studies have explored the use of medicinal plants and/or their active derivatives to inhibit excessive stimulation of the inflammasomes and its associated factors, thus reducing immunopathological response in the host.
This review describes the molecular mechanism of the NLRP3 inflammasome activation in the alveoli during M. tuberculosis infection.
Furthermore, the mechanisms of inflammasome inhibition using medicinal plant and their derivatives will also be explored, thus offering a novel perspective on the alternative control strategies of M. tuberculosis-induced immunopathology.
Exploring the Use of Medicinal Plants and Their Bioactive Derivatives as Alveolar NLRP3 Inflammasome Regulators during Mycobacterium tuberculosis Infection

Adjunct n-3 Long-Chain Polyunsaturated Fatty Acid Treatment in Tuberculosis Reduces Inflammation and Improves Anemia of Infection More in C3HeB/FeJ Mice With Low n-3 Fatty Acid Status Than Sufficient n-3 Fatty Acid Status

Populations at risk for tuberculosis (TB) may have a low n-3 polyunsaturated fatty acid (PUFA) status. Our research previously showed that post-infection supplementation of n-3 long-chain PUFA (LCPUFA) in TB without TB medication was beneficial in n-3 PUFA sufficient but not in low-status C3HeB/FeJ mice.
In this study, we investigated the effect of n-3 LCPUFA adjunct to TB medication in TB mice with a low compared to a sufficient n-3 PUFA status. Mice were conditioned on an n-3 PUFA-deficient (n-3FAD) or n-3 PUFA-sufficient (n-3FAS) diet for 6 weeks before TB infection.
Post-infection at 2 weeks, both groups were switched to an n-3 LCPUFA [eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA)] supplemented diet and euthanized at 4- and 14- days post-treatment. Iron and anemia status, bacterial loads, lung pathology, lung cytokines/chemokines, and lung lipid mediators were measured.
Following 14 days of treatment, hemoglobin (Hb) was higher in the n-3FAD than the untreated n-3FAS group (p = 0.022), whereas the n-3FAS (drug) treated control and n-3FAS groups were not.
Pro-inflammatory lung cytokines; interleukin-6 (IL-6) (p = 0.011), IL-1α (p = 0.039), MCP1 (p = 0.003), MIP1- α (p = 0.043), and RANTES (p = 0.034); were lower, and the anti-inflammatory cytokine IL-4 (p = 0.002) and growth factor GMCSF (p = 0.007) were higher in the n-3FAD compared with the n-3FAS mice after 14 days.
These results suggest that n-3 LCPUFA therapy in TB-infected mice, in combination with TB medication, may improve anemia of infection more in low n-3 fatty acid status than sufficient status mice.
Furthermore, the low n-3 fatty acid status TB mice supplemented with n-3 LCPUFA showed comparatively lower cytokine-mediated inflammation despite presenting with lower pro-resolving lipid mediators.

Exploring the Use of Medicinal Plants and Their Bioactive Derivatives as Alveolar NLRP3 Inflammasome Regulators during Mycobacterium tuberculosis InfectionChildhood Tuberculosis: An Under Prioritized Disease in Nepal

Globally, childhood tuberculosis constitutes up to 10% of overall tuberculosis cases. In Nepal, childhood tuberculosis has remained around 5.5% of overall tuberculosis cases and has remained stagnant over the years.
Moreover, our health system is focused on adult tuberculosis. Childhood tuberculosis has recently got its attention both at the national and international levels.
National Tuberculosis Program has been a successful program; however, more has to be done to track childhood tuberculosis progress. In this viewpoint, we discuss current initiatives taken by the government and the way forward for case detection and management of childhood tuberculosis in Nepal.

Analysis of the application of a gene chip method for detecting Mycobacterium tuberculosis drug resistance in clinical specimens: a retrospective study

Most Mycobacterium tuberculosis (Mtb) resistant to rifampicin (RIF) has mutations in the rpoB gene, while most Mtb resistant to isoniazid (INH) has mutations in the katG gene or inhA promoter.
We used gene chip technology to detect mutations in these genes to determine the resistance of Mtb to RIF and INH. A total of 4148 clinical specimens with sputum smear positivity for acid-fast bacilli (AFB) were detected.
Then, taking the results of the drug sensitivity test (DST) as the reference standard, the detection efficiency of sputum samples from different grades of positive smears was compared in detail.
Exploring the Use of Medicinal Plants and Their Bioactive Derivatives as Alveolar NLRP3 Inflammasome Regulators during Mycobacterium tuberculosis Infection
We found that the sensitivity of the gene chip method for detecting sputum samples with a grade ≥ AFB 2 + was higher than that of sputum samples with a grade ≤ AFB 1 + (P < 0.05).
When the grade of the sample was ≤ AFB 1 +, the sensitivity of the gene chip method was 72.6% for RIF, 67.3% for INH, and 60.0% for MDR-TB. When the grade of the sample was ≥ AFB 2 +, the sensitivity of the gene chip method was 84.5% for RIF, 78.2% for INH, and 73.9% for MDR-TB.
The results show that gene chip technology can be directly used to diagnose drug-resistant tuberculosis in clinical specimens, and the diagnostic efficiency for the detection of sputum specimens with a grade ≥ AFB 2 + is better than that of other sputum specimens.

Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients

Effective treatment reduces a tuberculosis patient’s ability to infect others even before they test negative in sputum or culture. Currently, the basis of reduced infectiousness of the Mycobacterium tuberculosis (Mtb) with effective treatment is unclear.
We evaluated changes in aerosolized bacteria expelled by patients through a transcriptomic approach before and after treatment initiation (up to 14 days) by RNA sequencing. A distinct change in the overall transcriptional profile was seen post-treatment initiation compared to pretreatment, only when patients received effective treatment.
This also led to the downregulation of genes associated with cellular activities, cell wall assembly, virulence factors indicating loss of pathogenicity, and a diminished ability to infect and survive in new host cells. Based on this, we identified genes whose expression levels changed with effective treatment.

M. Tuberculosis 16 kDa

DAG-T2449 1 mg Ask for price

M. Tuberculosis 15.3 kDa

DAGA-169 1 mg
EUR 1170

Mouse antibody for M. tuberculosis Hsp65

5177 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis Hsp65 for WB, ELISA.

Mouse antibody for M. tuberculosis Hsp65

5178 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis Hsp65 for WB, ELISA.

M. Tuberculosis TB22.2 Antigen

DAGA-186 100 µg
EUR 868.8

M. tuberculosis CFP10, Protein

abx061400-100ug 100 ug
EUR 961.2

M. tuberculosis ESAT6, Protein

abx061402-100ug 100 ug
EUR 910.8

M. Tuberculosis Mpt70 Antigen

DAGA-182 100 µg
EUR 868.8

M. Tuberculosis MPT83 Antigen

DAGA-183 100 µg
EUR 868.8

M. Tuberculosis Mpt64 Antigen

DAGA-184 100 µg
EUR 868.8

Recombinant Mycobacterium Tuberculosis HSP Protein

VAng-Yyj0063-10g 10 µg
EUR 2250
Description: Mycobacterium Tuberculosis, HSP, recombinant protein.

M. Tuberculosis Rv2672 Antigen

DAGA-174 100 µg
EUR 868.8

M. Tuberculosis Rv2253 Antigen

DAGA-177 100 µg
EUR 868.8

M. Tuberculosis MT3413 Antigen

DAGA-178 100 µg
EUR 868.8

M. Tuberculosis Rv0477 Antigen

DAGA-179 100 µg
EUR 868.8

M. Tuberculosis Rv0192A Antigen

DAGA-173 100 µg
EUR 868.8

M. Tuberculosis Rv0398c Antigen

DAGA-176 100 µg
EUR 868.8

M. Tuberculosis 38 kDa Protein

abx060636-100ug 100 ug
EUR 978

M. Tuberculosis 85-C Antigen

DAGA-175 100 µg
EUR 868.8

M. Tuberculosis 85-A Antigen

DAGA-181 100 µg
EUR 868.8

M. Tuberculosis 85-B Antigen

DAGA-185 100 µg
EUR 868.8

M. Tuberculosis 48 kDa protein

DAGA-191 1 mg Ask for price

Mycobacterium tuberculosis 38 kDa Antigen (M. tuberculosis 38 kDa) Antibody

abx411025-02mg 0.2 mg
EUR 678

Mycobacterium tuberculosis 16 kDa Antigen (M. tuberculosis 16 kDa) Antibody

abx415759-01mg 0.1 mg
EUR 760.8

M. Tuberculosis 85A Antigen[his]

DAGA-189 10 µg
EUR 812.4

M. Tuberculosis 85A Antigen [His]

DAGA-192 50 µg
EUR 1228.8

M. Tuberculosis ESAT-6 Antigen

DAGA-187 100 µg
EUR 868.8

Monoclonal Anti-M. tuberculosis Heat Shock Protein 70 (hsp70/Dnak/ML2496) IgG

HSP701-M 100 ul
EUR 578.4

Anti-Tb7.7 (M. tuberculosis) Purified

11-190-C100 0.1 mg
EUR 244.8

M. Tuberculosis Mpt63/MPB63 Antigen

DAGA-180 100 µg
EUR 868.8

Anti-Acr1 (M. tuberculosis) Purified

11-185-C100 0.1 mg
EUR 244.8

Anti-Tb10.4 (M. tuberculosis) Purified

11-186-C100 0.1 mg
EUR 244.8

Anti-Tb10.3 (M. tuberculosis) Purified

11-187-C100 0.1 mg
EUR 244.8

Anti-Acr2 (M. tuberculosis) Purified

11-188-C100 0.1 mg
EUR 244.8

Anti-GlcB (M. tuberculosis) Purified

11-192-C100 0.1 mg
EUR 244.8

Recombinant M. Tuberculosis CFP-10

DAGA-170 1 mg
EUR 790.8

M. Tuberculosis 63 kDa protein [His]

DAGA-190 1 mg Ask for price

Anti-Ag85b (M. tuberculosis) Purified

11-189-C100 0.1 mg
EUR 244.8

Zmp1 M. tuberculosis Recombinant Protein

90-361 50 ug
EUR 752.1
Description: M13 endopeptidases are single-pass, transmembrane zinc-metallopeptidases responsible in human for the regulation of the biological activity of many hormones and peptides and are involved in many important processes such as blood pressure regulation (Neprilysin or NEP1), cardiovascular development (Endothelin Converting Enzyme-1 or ECE-12), prevention of haemolytic reaction (KELL) and phosphate homeostasis (PHEX). Zmp1 is a soluble enzyme member of the M13 endopeptidases family that plays a key role in Mycobacterium tuberculosis pathogenicity with a still unknown mechanism. Recently, it was shown to suppress inflammasome activation by inhibiting caspase-1 activation, thus preventing processing of pro-IL-1beta into IL-1beta and the consequent phagosome maturation.

Recombinant M. Tuberculosis Moex antigen

DAGA-213 1 mg Ask for price

M. Tuberculosis EsxB (LHP) (CFP10) Antigen

DAGA-188 100 µg
EUR 868.8

M. Tuberculosis ClpP Protease Assay Kit

TBP100K 100 assays
EUR 278.4
Description: This product includes 3100 ul of Assay Buffer and 310 ul of 10 x Substrate and 3500 ul of Stop solution. It is for 100 assays in 384-well plate format

Anti-CFP-10 (M. tuberculosis) Purified

11-490-C025 0.025 mg
EUR 146.4

Anti-CFP-10 (M. tuberculosis) Purified

11-490-C100 0.1 mg
EUR 244.8

Anti-ESAT-6 (M. tuberculosis) Purified

11-491-C025 0.025 mg
EUR 146.4

Anti-ESAT-6 (M. tuberculosis) Purified

11-491-C100 0.1 mg
EUR 244.8

Mouse antibody for M. tuberculosis CFP10

5172 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis CFP10 for WB, ELISA.

Mouse antibody for M. tuberculosis ESAT6

5173 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis ESAT6 for WB, ELISA.

Mouse antibody for M. tuberculosis 38kDa

5174 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis 38kDa for WB, ELISA.

M. tuberculosis 38 kDa recombinant antigen

8811 100 ug
EUR 477.6
Description: This is M. tuberculosis 38 kDa recombinant antigen for ELISA,WB.

Mouse antibody for M. tuberculosis 16 kDa

5175 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis 16 kDa for WB, ELISA.

Mouse antibody for M. tuberculosis 16 kDa

5176 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against M tuberculosis 16 kDa for WB, ELISA.

M. Tuberculosis p60-Related Protein Rv0024

DAGA-172 100 µg
EUR 868.8

Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody

20-abx109426
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

M. Tuberculosis ClpP Protease Assay Kit Plus

TBP100KE 100 assays
EUR 467.15
Description: This product includes 3000 ul of Assay Buffer, 310 ul of 10 x Substrate, 3500 ul of Stop solution and 31 ul of 100 x Mtb ClpP1P2 protease. It is for 100 assays in 384-well plate format

Rabbit polyclonal antibody for M. tuberculosis

304 1 ml
EUR 386.26
Description: This is HRP conjugated rabbit polyclonal antibody against M tuberculosis all antigens for WB, ELISA.

Rabbit polyclonal antibody for M. tuberculosis

4601 1 ml
EUR 340.57
Description: This is rabbit polyclonal antibody against M tuberculosis all antigens for WB, ELISA.

Rabbit polyclonal antibody for M. tuberculosis

4603 1 ml
EUR 360.16
Description: This is FITC conjugated rabbit polyclonal antibody against M tuberculosis all antigens for WB, ELISA.

Rabbit polyclonal antibody for M. tuberculosis

4607 1 ml
EUR 360.16
Description: This is Biotin conjugated rabbit polyclonal antibody against M tuberculosis all antigens for WB, ELISA.

NAD Kinase M. tuberculosis Recombinant Protein

90-365 50 ug
EUR 651.3
Description: NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis. NAD kinase from Mycobacterium tuberculosis is not ATP-dependent but has a broader substrate specificity than human NAD kinase. It can economically produce NADP+ by using other nucleoside triphosphates as well as inorganic polyphosphate as a source of phosphorus. Was identified as a high-confidence drug target. Catalytic activity: ATP + NAD+ = ADP + NADP+

Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (Biotin)

20-abx106339
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (FITC)

20-abx107752
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] (M. tuberculosis inhA) Antibody (HRP)

20-abx109170
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

NAD Synthetase M. tuberculosis Recombinant Protein

90-366 50 ug
EUR 752.1
Description: NAD synthetase is an essential enzyme involved in both the de novo biosynthesis and salvage of NAD+, catalyzing the final step of both pathways. Since NAD has a vital role in cell metabolism, the enzyme represents a valid target for the development of new antimycobacterial agents. It can use both glutamine or ammonia as a nitrogen source. Catalytic activity: ATP + deamido-NAD+ + L-glutamine + H2O = AMP + diphosphate + NAD+ + L-glutamate

Recombinant M. Tuberculosis EspC/Rv3615c(H37Rv) [His]

DAGA-3055 100ug
EUR 764.4

IgG Antibody to M. Tuberculosis, TB-IgG ELISA Kit

DEIA083 96T
EUR 676.8
Description: This kit is anenzyme-linked immunosorbent assay for qualitative detection of IgG antibodies to Mycobacterium tuberculosis in human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by M. tuberculosis and other Mycobacteria.

Recombinant purified M. tuberculosis Heat Shock Protein 70 (hsp70/hsp72/Dnak/ML2496) control for Western

HSP701-C 100 ul
EUR 343.2

Recombinant M. Tuberculosis CFP10: ESAT6 Chimera protein

DAGA-193 1 mg
EUR 2042.4

Recombinant Heat Shock Protein-70, Mycobacterium Tuberculosis

DAG560 100ug
EUR 1194

Mycobacterium tuberculosis

PCR-VH201-PCRVH20148D PCR-VH201-48D
EUR 230

Mycobacterium tuberculosis

PCR-VH201-PCRVH20196D PCR-VH201-96D
EUR 312

Mycobacterium tuberculosis

Oneq-VH201-OneqVH201100D Oneq-VH201-100D
EUR 515

Mycobacterium tuberculosis

Oneq-VH201-OneqVH201150D Oneq-VH201-150D
EUR 594

Mycobacterium tuberculosis

Oneq-VH201-OneqVH20150D Oneq-VH201-50D
EUR 413

Mycobacterium tuberculosis Hsp65 Antibody

abx022091-1mg 1 mg
EUR 1296

Recombinant M. tuberculosis Ag85A Protein, His, E.coli-1mg

QP8929-ec-1mg 1mg
EUR 2763.6

Recombinant M. tuberculosis Ag85C Protein, His, E.coli-1mg

QP7382-ec-1mg 1mg
EUR 2763.6

Recombinant M. tuberculosis INHA Protein, His, Yeast-1mg

QP7385-ye-1mg 1mg
EUR 3296.4

Recombinant Mycobacterium Tuberculosis vapB34 Protein (aa 1-70)

VAng-Yyj0339-50gEcoli 50 µg (E. coli)
EUR 1576.8
Description: Mycobacterium Tuberculosis Putative antitoxin VapB34 (vapB34), recombinant protein.

Recombinant M. tuberculosis Ag85B Protein, His, Yeast-1mg

QP7004-ye-1mg 1mg
EUR 3296.4

Recombinant M. tuberculosis Ag85A Protein, His, E.coli-10ug

QP8929-ec-10ug 10ug
EUR 391.2

Recombinant M. tuberculosis Ag85A Protein, His, E.coli-50ug

QP8929-ec-50ug 50ug
EUR 522

Recombinant M. tuberculosis Ag85C Protein, His, E.coli-10ug

QP7382-ec-10ug 10ug
EUR 391.2

Recombinant M. tuberculosis Ag85C Protein, His, E.coli-50ug

QP7382-ec-50ug 50ug
EUR 522

Recombinant M. tuberculosis INHA Protein, His, Yeast-10ug

QP7385-ye-10ug 10ug
EUR 434.4

Recombinant M. tuberculosis INHA Protein, His, Yeast-50ug

QP7385-ye-50ug 50ug
EUR 576

Heat shock protein (M. leprae/M. tuberculosis HSP65; 417-429) P38 peptide (AGGGVTLLQAAPALD, MW:1353.5)

HSP652-P 1 mg
EUR 182.4

Tuberculosis IgG ELISA kit

55R-IB79284 96 wells
EUR 382.8
Description: ELISA kit for the detection of Tuberculosis IgG in the research laboratory

Tuberculosis IgM ELISA kit

55R-IB79285 96 wells
EUR 382.8
Description: ELISA kit for the detection of Tuberculosis IgM in the research laboratory

Tuberculosis IgG ELISA Kit

DEIA1023 96T
EUR 654
Description: This kit is an enzyme-linked immunosorbent assay for qualitative detection of IgG antibodies to Mycobacterium tuberculosis in human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by M. tuberculosis and other Mycobacteria.

Tuberculosis CFP10 antibody

10-7852 1 mg
EUR 603.6
Description: Mouse monoclonal Tuberculosis CFP10 antibody

Tuberculosis CFP10 antibody

10-7853 1 mg
EUR 603.6
Description: Mouse monoclonal Tuberculosis CFP10 antibody

Recombinant M. tuberculosis Ag85B Protein, His, Yeast-10ug

QP7004-ye-10ug 10ug
EUR 434.4

Recombinant M. tuberculosis Ag85B Protein, His, Yeast-50ug

QP7004-ye-50ug 50ug
EUR 576

Recombinant M. tuberculosis Ag85A Protein, His, E.coli-100ug

QP8929-ec-100ug 100ug
EUR 848.4

Recombinant M. tuberculosis Ag85A Protein, His, E.coli-200ug

QP8929-ec-200ug 200ug
EUR 1338

Recombinant M. tuberculosis Ag85A Protein, His, E.coli-500ug

QP8929-ec-500ug 500ug
EUR 1816.8

Recombinant M. tuberculosis Ag85C Protein, His, E.coli-100ug

QP7382-ec-100ug 100ug
EUR 848.4

Recombinant M. tuberculosis Ag85C Protein, His, E.coli-200ug

QP7382-ec-200ug 200ug
EUR 1338

Recombinant M. tuberculosis Ag85C Protein, His, E.coli-500ug

QP7382-ec-500ug 500ug
EUR 1816.8

Recombinant M. tuberculosis INHA Protein, His, Yeast-100ug

QP7385-ye-100ug 100ug
EUR 945.6

Recombinant M. tuberculosis INHA Protein, His, Yeast-200ug

QP7385-ye-200ug 200ug
EUR 1512

Recombinant M. tuberculosis INHA Protein, His, Yeast-500ug

QP7385-ye-500ug 500ug
EUR 2164.8

Myobacterium Tuberculosis DnaK (HSP70) Protein

20-abx263478
  • EUR 2047.20
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 10 ug
  • 2 µg

Recombinant M. tuberculosis Ag85B Protein, His, Yeast-100ug

QP7004-ye-100ug 100ug
EUR 945.6

Recombinant M. tuberculosis Ag85B Protein, His, Yeast-200ug

QP7004-ye-200ug 200ug
EUR 1512

Recombinant M. tuberculosis Ag85B Protein, His, Yeast-500ug

QP7004-ye-500ug 500ug
EUR 2164.8

Recombinant Mycobacterium Tuberculosis Protein (full length, 70 kDa)

VAng-Yyj0145-100g 100 µg
EUR 1548
Description: Mycobacterium Tuberculosis, recombinant protein (full length, 70 kDa).

Pyrroline-5-caroxylate reductase, M. tuberculosis Recombinant

P1456-10 each
EUR 314.4

Pyrroline-5-caroxylate reductase, M. tuberculosis Recombinant

P1456-50 each
EUR 1083.6

Recombinant Myobacterium Tuberculosis DnaK (HSP70)

7-06958 2µg Ask for price

Recombinant Myobacterium Tuberculosis DnaK (HSP70)

7-06959 10µg Ask for price

Recombinant Myobacterium Tuberculosis DnaK (HSP70)

7-06960 100µg Ask for price

Myobacterium Tuberculosis DnaK (HSP70) , (Recombinant)

22060737-1 2 µg
EUR 137.27

Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-1mg

QP7385-ec-1mg 1mg
EUR 2763.6

Mouse Anti-M. Tuberculosis 16kDa/Hspx IgG ELISA kit, 96 tests, Quantitative

990-240-16G 1 Kit
EUR 927.6

Mouse Anti-M. Tuberculosis 16kDa/Hspx IgM ELISA kit, 96 tests, Quantitative

990-245-16M 1 Kit
EUR 927.6

Human Tuberculosis (TB) ELISA Kit

abx055763-96tests 96 tests
EUR 801.6

Goat tuberculosis IgG ELISA Kit

ELA-E2192g 96 Tests
EUR 1113.6

Human Tuberculosis (TB) ELISA Kit

SL2799Hu 96 Tests
EUR 468

Recombinant purified M. tuberculosis antigen (16kDa/Hspx) control for Western

MTB161-C 100 ul
EUR 343.2

Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-1mg

QP7004-ec-1mg 1mg
EUR 2763.6

Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-10ug

QP7385-ec-10ug 10ug
EUR 391.2

Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-50ug

QP7385-ec-50ug 50ug
EUR 522

Recombinant purified Mycobacterium Tuberculosis Heat Shock Protein 70 (hsp70/Dnak/ML2496)

RP-628 10 ug
EUR 343.2

Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-50ug

QP7004-ec-50ug 50ug
EUR 522

Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-100ug

QP7385-ec-100ug 100ug
EUR 848.4

Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-200ug

QP7385-ec-200ug 200ug
EUR 1338

Recombinant M. tuberculosis INHA Protein, His-SUMO, E.coli-500ug

QP7385-ec-500ug 500ug
EUR 1816.8

Monoclonal Anti-M. tuberculosis Heat Shock Protein 65 (hsp65/groEL-2/Cpn60-2) IgG

HSP651-M 100 ul
EUR 578.4

Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-100ug

QP7004-ec-100ug 100ug
EUR 848.4

Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-200ug

QP7004-ec-200ug 200ug
EUR 1338

Recombinant M. tuberculosis Ag85B Protein, His-SUMO, E.coli-500ug

QP7004-ec-500ug 500ug
EUR 1816.8

Mycobacterium tuberculosis antibody

20-MR50 1 mg
EUR 139.2
Description: Rabbit polyclonal Mycobacterium tuberculosis antibody

Mycobacterium tuberculosis Antibody

abx022066-1mg 1 mg
EUR 1220.4

Mycobacterium tuberculosis Antibody

abx022067-1mg 1 mg
EUR 1296

Mycobacterium tuberculosis Antibody

abx022073-1mg 1 mg
EUR 1296

Mycobacterium tuberculosis Antibody

abx022087-1mg 1 mg
EUR 994.8

Mycobacterium tuberculosis Antibody

abx022088-1mg 1 mg
EUR 994.8

Mycobacterium tuberculosis Antibody

abx022089-1mg 1 mg
EUR 944.4

Mycobacterium tuberculosis Antibody

abx022090-1mg 1 mg
EUR 944.4

Mycobacterium tuberculosis Antibody

abx023092-1ml 1 ml
EUR 718.8

Mycobacterium tuberculosis PCR kit

PCR-VH201-48D 50T
EUR 543.6

Mycobacterium tuberculosis PCR kit

PCR-VH201-96D 100T
EUR 686.4

Tuberculosis IgG/IgM/IgA ELISA Kit

DEIA1979 96T
EUR 988.8
Description: The Tuberculosis ELISA has been designed for measurement of specific IgG/IgM/IgA antibodies respectively against Mycobacterium tuberculosis in serum and plasma. Further applications in other body fluids are possible and can be provided on request.

Bacteria-Derived Zmp1 M. tuberculosis Recombinant Protein His Tag

IBCTZMP1MTBRHIS50UG each
EUR 899
Description: Bacteria-Derived Zmp1 M. tuberculosis Recombinant Protein His Tag

Human Tuberculosis (TB) IgG ELISA Kit

abx364946-96tests 96 tests
EUR 764.4

Tuberculosis Ag MPT64 specific test

08FK50 25 tests/kit
EUR 67.65

Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-10ug

QP9476-ye-10ug 10ug
EUR 434.4

Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-1mg

QP9476-ye-1mg 1mg
EUR 3296.4

Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-50ug

QP9476-ye-50ug 50ug
EUR 576

ELISA kit for Bovine Tuberculosis (TB)

KTE10464-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Bovine Tuberculosis (TB) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Bovine Tuberculosis (TB)

KTE10464-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Bovine Tuberculosis (TB) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Bovine Tuberculosis (TB)

KTE10464-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Bovine Tuberculosis (TB) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Mycobacterium tuberculosis RT PCR kit

RTq-VH201-100D 100T
EUR 860.4

Mycobacterium tuberculosis RT PCR kit

RTq-VH201-150D 150T
EUR 969.6

Mycobacterium tuberculosis RT PCR kit

RTq-VH201-50D 50T
EUR 717.6

Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-200ug

QP9476-ye-200ug 200ug
EUR 1512

Recombinant M. tuberculosis Antitoxin MT2731 Protein, His, Yeast-500ug

QP9476-ye-500ug 500ug
EUR 2164.8

Mycobacterium Tuberculosis MoeX Protein

20-abx260302
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Mycobacterium tuberculosis Antibody (HRP)

abx023091-1ml 1 ml
EUR 777.6

Recombinant M. tuberculosis Signal peptidase I Protein, His, Yeast-10ug

QP7516-ye-10ug 10ug
EUR 434.4

Recombinant M. tuberculosis Signal peptidase I Protein, His, Yeast-1mg

QP7516-ye-1mg 1mg
EUR 3296.4

Recombinant M. tuberculosis Signal peptidase I Protein, His, Yeast-50ug

QP7516-ye-50ug 50ug
EUR 576

Trehalose 6,6?-dimycolate [TDM/Cord Factor], M. tuberculosis, Endotoxin-free

TDM15-N-100 100 ug
EUR 270

DnaK (HSP70) Mycobacterium Tuberculosis Recombinant Protein

PROTP19993 Regular: 10ug
EUR 380.4
Description: Recombinant Mycobacterium Tuberculosis Dnak produced in E.Coli is a single, non-glycosylated polypeptide chain containing 625 amino acids and having a molecular mass of 66.7 kDa.

CFP10 protein (Mycobacterium tuberculosis)

30R-3240 50 ug
EUR 584.4
Description: Purified recombinant CFP10 protein (Mycobacterium tuberculosis)

Mycobacterium tuberculosis Antibody (FITC)

abx023089-1ml 1 ml
EUR 718.8

Mycobacterium tuberculosis IgG ELISA Kit

DEIA381 96T
EUR 674.4
Description: The Mycobacterium tuberculosis IgG antibody ELISA kit has been designed for the detection andthe quantitative determination of specific IgG antibodies against Mycobacterium tuberculosis in serum and plasma.

Mycobacterium tuberculosis IgA ELISA Kit

DEIA382 96T
EUR 696
Description: The Mycobacterium tuberculosis IgA antibody ELISA kit has been designed for the detection andthe quantitative determination of specific IgA antibodies against Mycobacterium tuberculosis in serum and plasma.

Mycobacterium tuberculosis IgM ELISA Kit

DEIA383 96T
EUR 696
Description: The Mycobacterium tuberculosis IgM antibody ELISA kit has been designed for the detection andthe quantitative determination of specific IgM antibodies against Mycobacterium tuberculosis in serum and plasma.

Purification of tuberculosis LPS Antigen

E41H008 100ug
EUR 495

Tuberculosis (TB)  Interferon-γ array kit

VArk-Lsx003 unit Ask for price
Description: Used in Interferon Gamma Release Assay (IGRA) to detect Tuberculosis (TB)

Mycobacterium tuberculosis CFP10 Antibody

abx022068-1mg 1 mg
EUR 1111.2

Mycobacterium tuberculosis CFP10 Antibody

abx022069-1mg 1 mg
EUR 1111.2

Mycobacterium tuberculosis CFP10 Antibody

abx022070-1mg 1 mg
EUR 1111.2

Mycobacterium tuberculosis ESAT6 Antibody

abx022071-1mg 1 mg
EUR 1111.2
The observations of the study open up avenues for further evaluating the changes in bacterial gene expression during the early phase of treatment as biomarkers for monitoring response to tuberculosis treatment regimens and provide means of identifying better correlates of Mtb transmission.

LEAVE A REPLY

Please enter your comment!
Please enter your name here